Investigating a new gene's role in blood vessel growth in pulmonary arterial hypertension.
PBK: A novel mediator of VSMC proliferation and vascular remodeling in PAH
This study is looking at a new gene called PBK to see how it affects the growth of blood vessel cells in people with pulmonary arterial hypertension (PAH), with the hope that understanding this gene could lead to better treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Augusta University NIH-funded |
| Lab location | 1 site (Augusta, United States) |
| Project ID | NIH-10850598 on NIH RePORTER |
What this research studies
This research focuses on pulmonary arterial hypertension (PAH), a serious condition characterized by high blood pressure in the lungs that leads to heart failure. The study aims to understand the role of a newly discovered gene, PBK, which is linked to excessive growth of vascular cells in PAH. By using animal models, the researchers will explore how PBK influences the remodeling of pulmonary arteries and whether targeting this gene can provide new therapeutic options. Patients may benefit from insights that could lead to more effective treatments for PAH.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with pulmonary arterial hypertension who are experiencing limited treatment options.
Not a fit: Patients with mild pulmonary hypertension or those whose condition is not primarily driven by vascular remodeling may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that effectively reverse the vascular remodeling associated with pulmonary arterial hypertension.
How similar studies have performed: While the approach of targeting PBK in PAH is novel, similar strategies in cancer research have shown promising results, suggesting potential for success in this context.
Where this research is happening
Augusta, United States
- Augusta University — Augusta, United States (Active)
Researchers
- Principal investigator: Fulton, David J — Augusta University
- Study coordinator: Fulton, David J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.